UnknownNot Applicable

Efficacy of Extracorporeal Shockwave Therapy on Ultrasonographic Changes in de Quervain Tenosynovitis

Egypt60 participantsStarted 2023-04-01

Plain-language summary

The current study will be conducted to explore the efficacy of ESWT on ultrasonographic changes, pain intensity level, upper limb function and hand grip strength in patients with de Quervain tenosynovitis.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age from 18 to 65 years
✓. Both genders (males and females).
✓. Normal BMI ranges between 18.5:24.9 kg/m2.
✓. Patients will be referred from an orthopedist with diagnosis of DQT.
✓. Chronic pain more than 2 months.
✓. No history of undergoing physiotherapy modalities or corticosterone injection therapies for any reasons during the past month.
✓. De Quervain tenosynovitis patients will be diagnosed based on the standard criteria, including pain and tenderness in the lateral wrist and a positive result for the Finkelstein test.

Exclusion criteria

✕. History of undergoing physiotherapy modalities or corticosterone injection therapies for any reason during the past month.
✕. Subjects with other neurological disorders rheumatologic diseases causing wrist pain.
✕. Pregnancy.
✕. History of fracture or surgery on the hand.
✕. Severe trauma, and coagulation disorders.

What they're measuring

Ultrasonographic Changes: Thickness in tendons:

Timeframe: Up to Four weeks

Ultrasonographic Changes: Color Doppler activity

Timeframe: Up to Four weeks

Trial details

NCT IDNCT05782114

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04

Contact for this trial

Mostafa G Mahmoud, phd

0201122425299 darsh9lover@gmail.com

View on ClinicalTrials.gov More De Quervain Disease trials